Ulrich Brinkmann, Ph.D.Expert Scientist, Large Molecule Research, Pharma Research & Early Development at Roche Innovation Center, Munich
Dr. Ulrich Brinkmann (PhD) is a member of Roche’s Large Molecule Research organization within Pharma Research & Early Development at the Roche Innovation Center Munich (Penzberg, Germany). His current work focuses on protein & antibody engineering, bispecifics, and on delivery platforms for targeted payload delivery. Before joining Roche, he served as CSO in functional genomics and pharmacogenetics companies Xantos and Epidauros. Prior to that, he focused on antibody stabilization and engineering technologies, and on generating recombinant immunotoxins for cancer therapy in Ira Pastans Molecular Biology Lab at the NIH/NCI in Bethesda.